129 related articles for article (PubMed ID: 33617403)
1. Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
Skalleberg J; Myhrum M; Småstuen MC; Osnes TA; Fosså SD; Bunne M
Acta Oncol; 2021 Apr; 60(4):426-433. PubMed ID: 33617403
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up.
Skalleberg J; Småstuen MC; Oldenburg J; Osnes T; Fosså SD; Bunne M
Laryngoscope; 2020 Sep; 130(9):E515-E521. PubMed ID: 32065408
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.
Frisina RD; Wheeler HE; Fossa SD; Kerns SL; Fung C; Sesso HD; Monahan PO; Feldman DR; Hamilton R; Vaughn DJ; Beard CJ; Budnick A; Johnson EM; Ardeshir-Rouhani-Fard S; Einhorn LH; Lipshultz SE; Dolan ME; Travis LB
J Clin Oncol; 2016 Aug; 34(23):2712-20. PubMed ID: 27354478
[TBL] [Abstract][Full Text] [Related]
4. Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
Skalleberg J; Solheim O; Fosså SD; Småstuen MC; Osnes T; Gundersen POM; Bunne M
Gynecol Oncol; 2017 Apr; 145(1):148-153. PubMed ID: 28202195
[TBL] [Abstract][Full Text] [Related]
5. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
Haugnes HS; Stenklev NC; Brydøy M; Dahl O; Wilsgaard T; Laukli E; Fosså SD
Acta Oncol; 2018 Aug; 57(8):1075-1083. PubMed ID: 29384420
[TBL] [Abstract][Full Text] [Related]
6. Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.
Ardeshirrouhanifard S; Fossa SD; Huddart R; Monahan PO; Fung C; Song Y; Dolan ME; Feldman DR; Hamilton RJ; Vaughn D; Martin NE; Kollmannsberger C; Dinh P; Einhorn L; Frisina RD; Travis LB
Ear Hear; 2022; 43(3):794-807. PubMed ID: 35067571
[TBL] [Abstract][Full Text] [Related]
7. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity?
Schultz C; Pecora Liberman PH; Schmidt Goffi-Gomez MV
Audiol Neurootol; 2019; 24(5):253-257. PubMed ID: 31661686
[TBL] [Abstract][Full Text] [Related]
8. The relationship between high-frequency pure-tone hearing loss, hearing in noise test (HINT) thresholds, and the articulation index.
Vermiglio AJ; Soli SD; Freed DJ; Fisher LM
J Am Acad Audiol; 2012; 23(10):779-88. PubMed ID: 23169195
[TBL] [Abstract][Full Text] [Related]
9. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
Biró K
Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.
Sanchez VA; Dinh PC; Rooker J; Monahan PO; Althouse SK; Fung C; Sesso HD; Einhorn LH; Dolan ME; Frisina RD; Travis LB
J Cancer Surviv; 2023 Feb; 17(1):27-39. PubMed ID: 36637632
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
Biro K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Oncology; 2006; 70(3):177-84. PubMed ID: 16757924
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
BMC Cancer; 2021 Jul; 21(1):822. PubMed ID: 34271863
[TBL] [Abstract][Full Text] [Related]
13. Cortical Auditory Evoked Potential Indices of Impaired Sensory Gating in People With Chronic Tinnitus.
Morse K; Vander Werff KR
Ear Hear; 2024 May-Jun 01; 45(3):730-741. PubMed ID: 38273451
[TBL] [Abstract][Full Text] [Related]
14. Speech reception in quiet and in noisy conditions by individuals with noise-induced hearing loss in relation to their tone audiogram.
Smoorenburg GF
J Acoust Soc Am; 1992 Jan; 91(1):421-37. PubMed ID: 1737889
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
Bokemeyer C; Berger CC; Hartmann JT; Kollmannsberger C; Schmoll HJ; Kuczyk MA; Kanz L
Br J Cancer; 1998 Apr; 77(8):1355-62. PubMed ID: 9579846
[TBL] [Abstract][Full Text] [Related]
16. Understanding excessive SNR loss in hearing-impaired listeners.
Grant KW; Walden TC
J Am Acad Audiol; 2013 Apr; 24(4):258-73; quiz 337-8. PubMed ID: 23636208
[TBL] [Abstract][Full Text] [Related]
17. Tinnitus Affects Speech in Noise Comprehension in Individuals With Hearing Loss.
Oosterloo BC; Homans NC; Goedegebure A
Otol Neurotol; 2020 Oct; 41(9):e1074-e1081. PubMed ID: 32925836
[TBL] [Abstract][Full Text] [Related]
18. A new grading system for ototoxicity in adults.
Theunissen EA; Dreschler WA; Latenstein MN; Rasch CR; van der Baan S; de Boer JP; Balm AJ; Zuur CL
Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):711-8. PubMed ID: 24820112
[TBL] [Abstract][Full Text] [Related]
19. Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aids.
Einarsson EJ; Petersen H; Wiebe T; Fransson PA; Magnusson M; Moëll C
Int J Audiol; 2011 Oct; 50(10):642-51. PubMed ID: 21812630
[TBL] [Abstract][Full Text] [Related]
20. Extended high frequency hearing and speech perception implications in adults and children.
Hunter LL; Monson BB; Moore DR; Dhar S; Wright BA; Munro KJ; Zadeh LM; Blankenship CM; Stiepan SM; Siegel JH
Hear Res; 2020 Nov; 397():107922. PubMed ID: 32111404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
